Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
S-propylamine-L-cysteine is a synthetic small molecule and an experimental compound with the molecular formula C6H16N2OS and a molecular weight of approximately 164.27 g/mol[1][2][6]. It is structurally related to L-cysteine, featuring a propylamine group attached via a sulfur atom. The compound has been cataloged in chemical and drug databases but does not have any approved medical indications or established clinical uses as of now[1][9]. Its mechanism of action, pharmacological effects, and therapeutic potential remain uncharacterized in the scientific literature. No information on its biological targets or clinical development status beyond being listed as "experimental" is available.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on S-propylamine-L-cysteine.